Depression Disorder Research Study

Join a compensated research study funded by Weill Cornell Medicine aimed at studying the effectiveness of Transcranial Magnetic Stimulation (TMS) for the treatment of depression.

Fast Facts

Diagnosed With Depression

18-75 Years Old

Compensation Provided

Conducted in New York City

Study Background

The main goal of our study is to improve treatment methods for individuals struggling with depression.

New interventions are urgently needed to treat depression, as more than 17 million Americans are currently diagnosed with depression.

Our researchers are evaluating repetitive transcranial magnetic stimulation (rTMS) as a treatment for individuals with depression. rTMS uses focused magnetic field pulses to stimulate specific brain areas.

Contribute to the development of better treatment options for people living with depression by joining our study today.

Study Background

The main goal of our study is to improve treatment methods for individuals struggling with depression.

New interventions are urgently needed to treat depression, as more than 17 million Americans are currently diagnosed with depression.

Our researchers are evaluating repetitive transcranial magnetic stimulation (rTMS) as a treatment for individuals with depression. rTMS uses focused magnetic field pulses to stimulate specific brain areas.

Contribute to the development of better treatment options for people living with depression by joining our study today.

Additional Information

The primary goal of our study is to evaluate rTMS as a treatment for individuals with depression.

You may be eligible if:

  • You have a diagnosis of depression.

  • You are between 18 and 75 years of age.

  • You tried a medication and/or psychotherapy to treat your depression and it did not work or you could not tolerate it.

  • You are willing and able to participate in in-person MRI scans and daily TMS treatment sessions in New York City.

It may not be possible for you to participate if:

  • You have a history of seizures.

  • You have a neurological disorder.

  • It’s not safe or tolerable for you to have an MRI scan.

  • You have changed medications or medication dosages within the last month.

 

A more detailed review of eligibility will be conducted by the study team prior to enrollment.

  • In-person screening visit / diagnostic evaluation: clinical assessment, self-report questionnaires, blood draw, and pregnancy test (if applicable)
  • In-person treatment with Transcranial Magnetic Stimulation (TMS), 20 minutes per session
  • Weekly mood assessment and clinical check-ins with study psychiatrist for the duration of treatment
  • Two MRI scans (pre and post-treatment)
  • Longitudinal follow-up assessments clinical assessments and self-reports)

You may receive compensation for your participation.

There is no cost for you to participate in our research program.